表紙
市場調査レポート

進行性核上麻痺:世界の治験動向

Progressive Supranuclear Palsy Global Clinical Trials Review, H2, 2015

発行 GlobalData 商品コード 330732
出版日 ページ情報 英文 46 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
進行性核上麻痺:世界の治験動向 Progressive Supranuclear Palsy Global Clinical Trials Review, H2, 2015
出版日: 2015年11月25日 ページ情報: 英文 46 Pages
概要

当レポートでは、進行性核上麻痺に関する臨床研究の最新動向について分析しており、疾患・治療法の概要や、G7およびE7諸国における治験の状況、地域・フェーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤の比較といった情報を盛り込んでいます。

イントロダクション

  • 進行性核上麻痺
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数

G7諸国での治験件数:中枢神経系治療薬の治験における進行性核上麻痺の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数 進行性核上麻痺

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

進行性核上麻痺治療薬の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • Westat, Inc.
    • TauRx Pharmaceuticals Ltd.
    • Sellas Inc.
    • Paladin Labs Inc.
    • Noscira, S.A.
    • Mithridion, Inc.
  • 代表的な研究機関・病院の治験の概要
    • University of California, San Francisco
    • Centre Hospitalier Universitaire de Nantes
    • Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico
    • Georgetown University Medical Center
    • German Parkinson Association e.V.
    • Groupe Hospitalier Pitie-Salpetriere
    • King's College London
    • Ludwig Maximilians Universitat Munich
    • National Institute of Neurological Disorders and Stroke

5つの代表的な治験のプロファイル

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC2988CTIDB

GlobalData's clinical trial report, "Progressive Supranuclear Palsy Global Clinical Trials Review, H2, 2015" provides an overview of Progressive Supranuclear Palsy clinical trials scenario. This report provides top line data relating to the clinical trials on Progressive Supranuclear Palsy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Progressive Supranuclear Palsy to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Progressive Supranuclear Palsy Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials by Region, 2015*
  • Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Progressive Supranuclear Palsy Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Progressive Supranuclear Palsy Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Progressive Supranuclear Palsy Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Proportion of Progressive Supranuclear Palsy to Central Nervous System Clinical Trials, G7 Countries (%), 2015*
  • Progressive Supranuclear Palsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Progressive Supranuclear Palsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Progressive Supranuclear Palsy Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Progressive Supranuclear Palsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Progressive Supranuclear Palsy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Progressive Supranuclear Palsy Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Progressive Supranuclear Palsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Progressive Supranuclear Palsy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*

List of Figures

  • Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Progressive Supranuclear Palsy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Progressive Supranuclear Palsy Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Proportion of Progressive Supranuclear Palsy to Central Nervous System Clinical Trials, G7 Countries (%), 2015*
  • Progressive Supranuclear Palsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Progressive Supranuclear Palsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Progressive Supranuclear Palsy Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Progressive Supranuclear Palsy Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Progressive Supranuclear Palsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Progressive Supranuclear Palsy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Progressive Supranuclear Palsy Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Progressive Supranuclear Palsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Progressive Supranuclear Palsy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top